0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical R&D Outsourcing Services (CRO) Market Research Report 2026
Published Date: 2026-03-11
|
Report Code: QYRE-Auto-27O17636
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical R D Outsourcing Services CRO Market Research Report 2024
BUY CHAPTERS

Global Pharmaceutical R&D Outsourcing Services (CRO) Market Research Report 2026

Code: QYRE-Auto-27O17636
Report
2026-03-11
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical R&D Outsourcing Services (CRO) Market

The global Pharmaceutical R&D Outsourcing Services (CRO) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Pharmaceutical R&D Outsourcing Services (CRO) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Pharmaceutical R&D Outsourcing Services (CRO) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Pharmaceutical R&D Outsourcing Services (CRO) in Drug Discovery And Early Research is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Pharmaceutical R&D Outsourcing Services (CRO) include IQVIA HOLDINGS, ICON (incl. PRA Health), PPD(Pharmaceutical Product Development), Laboratory Corporation, Syneos Health, Parexel, Covance, Charles River Laboratories, Wuxi AppTec, Pharmaron Inc., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Pharmaceutical R&D Outsourcing Services (CRO) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical R&D Outsourcing Services (CRO). The Pharmaceutical R&D Outsourcing Services (CRO) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical R&D Outsourcing Services (CRO) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical R&D Outsourcing Services (CRO) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pharmaceutical R&D Outsourcing Services (CRO) Market Report

Report Metric Details
Report Name Pharmaceutical R&D Outsourcing Services (CRO) Market
Segment by Type
  • Chemical Drug Research And Development
  • Biological Drug Research And Development
  • Traditional Chinese Medicine Research And Development
Segment by Application
  • Drug Discovery And Early Research
  • Preclinical Research
  • Clinical Trials
  • Post-Marketing Follow-Up
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IQVIA HOLDINGS, ICON (incl. PRA Health), PPD(Pharmaceutical Product Development), Laboratory Corporation, Syneos Health, Parexel, Covance, Charles River Laboratories, Wuxi AppTec, Pharmaron Inc., Hangzhou Tigermed Consulting, IQVIA, Joinn Laboratories (China)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Pharmaceutical R&D Outsourcing Services (CRO) companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical R&D Outsourcing Services (CRO) Market report?

Ans: The main players in the Pharmaceutical R&D Outsourcing Services (CRO) Market are IQVIA HOLDINGS, ICON (incl. PRA Health), PPD(Pharmaceutical Product Development), Laboratory Corporation, Syneos Health, Parexel, Covance, Charles River Laboratories, Wuxi AppTec, Pharmaron Inc., Hangzhou Tigermed Consulting, IQVIA, Joinn Laboratories (China)

What are the Application segmentation covered in the Pharmaceutical R&D Outsourcing Services (CRO) Market report?

Ans: The Applications covered in the Pharmaceutical R&D Outsourcing Services (CRO) Market report are Drug Discovery And Early Research, Preclinical Research, Clinical Trials, Post-Marketing Follow-Up, Other

What are the Type segmentation covered in the Pharmaceutical R&D Outsourcing Services (CRO) Market report?

Ans: The Types covered in the Pharmaceutical R&D Outsourcing Services (CRO) Market report are Chemical Drug Research And Development, Biological Drug Research And Development, Traditional Chinese Medicine Research And Development

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Chemical Drug Research And Development
1.2.3 Biological Drug Research And Development
1.2.4 Traditional Chinese Medicine Research And Development
1.3 Market by Application
1.3.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Drug Discovery And Early Research
1.3.3 Preclinical Research
1.3.4 Clinical Trials
1.3.5 Post-Marketing Follow-Up
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Perspective (2021–2032)
2.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Growth Trends by Region
2.2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Region (2021–2026)
2.2.3 Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Region (2027–2032)
2.3 Pharmaceutical R&D Outsourcing Services (CRO) Market Dynamics
2.3.1 Pharmaceutical R&D Outsourcing Services (CRO) Industry Trends
2.3.2 Pharmaceutical R&D Outsourcing Services (CRO) Market Drivers
2.3.3 Pharmaceutical R&D Outsourcing Services (CRO) Market Challenges
2.3.4 Pharmaceutical R&D Outsourcing Services (CRO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Revenue
3.1.1 Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Revenue (2021–2026)
3.1.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Players (2021–2026)
3.2 Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical R&D Outsourcing Services (CRO) Revenue
3.4 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Concentration Ratio
3.4.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical R&D Outsourcing Services (CRO) Revenue in 2025
3.5 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO) Head Offices and Areas Served
3.6 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Products and Applications
3.7 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pharmaceutical R&D Outsourcing Services (CRO) Breakdown Data by Type
4.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Type (2021–2026)
4.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Type (2027–2032)
5 Pharmaceutical R&D Outsourcing Services (CRO) Breakdown Data by Application
5.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Application (2021–2026)
5.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2021–2032)
6.2 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2021–2026)
6.4 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2021–2032)
7.2 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2021–2026)
7.4 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2021–2032)
8.2 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2021–2026)
8.4 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2021–2032)
9.2 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2021–2026)
9.4 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2021–2032)
10.2 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2021–2026)
10.4 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA HOLDINGS
11.1.1 IQVIA HOLDINGS Company Details
11.1.2 IQVIA HOLDINGS Business Overview
11.1.3 IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.1.4 IQVIA HOLDINGS Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.1.5 IQVIA HOLDINGS Recent Development
11.2 ICON (incl. PRA Health)
11.2.1 ICON (incl. PRA Health) Company Details
11.2.2 ICON (incl. PRA Health) Business Overview
11.2.3 ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.2.4 ICON (incl. PRA Health) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.2.5 ICON (incl. PRA Health) Recent Development
11.3 PPD(Pharmaceutical Product Development)
11.3.1 PPD(Pharmaceutical Product Development) Company Details
11.3.2 PPD(Pharmaceutical Product Development) Business Overview
11.3.3 PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.3.4 PPD(Pharmaceutical Product Development) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.3.5 PPD(Pharmaceutical Product Development) Recent Development
11.4 Laboratory Corporation
11.4.1 Laboratory Corporation Company Details
11.4.2 Laboratory Corporation Business Overview
11.4.3 Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.4.4 Laboratory Corporation Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.4.5 Laboratory Corporation Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Details
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.5.4 Syneos Health Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.5.5 Syneos Health Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.6.4 Parexel Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.6.5 Parexel Recent Development
11.7 Covance
11.7.1 Covance Company Details
11.7.2 Covance Business Overview
11.7.3 Covance Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.7.4 Covance Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.7.5 Covance Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.8.4 Charles River Laboratories Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.8.5 Charles River Laboratories Recent Development
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Details
11.9.2 Wuxi AppTec Business Overview
11.9.3 Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.9.4 Wuxi AppTec Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.9.5 Wuxi AppTec Recent Development
11.10 Pharmaron Inc.
11.10.1 Pharmaron Inc. Company Details
11.10.2 Pharmaron Inc. Business Overview
11.10.3 Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.10.4 Pharmaron Inc. Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.10.5 Pharmaron Inc. Recent Development
11.11 Hangzhou Tigermed Consulting
11.11.1 Hangzhou Tigermed Consulting Company Details
11.11.2 Hangzhou Tigermed Consulting Business Overview
11.11.3 Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.11.4 Hangzhou Tigermed Consulting Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.11.5 Hangzhou Tigermed Consulting Recent Development
11.12 IQVIA
11.12.1 IQVIA Company Details
11.12.2 IQVIA Business Overview
11.12.3 IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.12.4 IQVIA Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.12.5 IQVIA Recent Development
11.13 Joinn Laboratories (China)
11.13.1 Joinn Laboratories (China) Company Details
11.13.2 Joinn Laboratories (China) Business Overview
11.13.3 Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.13.4 Joinn Laboratories (China) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
11.13.5 Joinn Laboratories (China) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Chemical Drug Research And Development
 Table 3. Key Players of Biological Drug Research And Development
 Table 4. Key Players of Traditional Chinese Medicine Research And Development
 Table 5. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2021–2026)
 Table 9. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2027–2032)
 Table 11. Pharmaceutical R&D Outsourcing Services (CRO) Market Trends
 Table 12. Pharmaceutical R&D Outsourcing Services (CRO) Market Drivers
 Table 13. Pharmaceutical R&D Outsourcing Services (CRO) Market Challenges
 Table 14. Pharmaceutical R&D Outsourcing Services (CRO) Market Restraints
 Table 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Players (2021–2026)
 Table 17. Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmaceutical R&D Outsourcing Services (CRO) Revenue, 2025
 Table 18. Ranking of Global Top Pharmaceutical R&D Outsourcing Services (CRO) Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Pharmaceutical R&D Outsourcing Services (CRO) Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Headquarters and Area Served
 Table 21. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Products and Applications
 Table 22. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Type (2021–2026)
 Table 26. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Type (2027–2032)
 Table 28. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Application (2021–2026)
 Table 30. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Application (2027–2032)
 Table 32. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2027–2032
 Table 47. IQVIA HOLDINGS Company Details
 Table 48. IQVIA HOLDINGS Business Overview
 Table 49. IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 50. IQVIA HOLDINGS Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 51. IQVIA HOLDINGS Recent Development
 Table 52. ICON (incl. PRA Health) Company Details
 Table 53. ICON (incl. PRA Health) Business Overview
 Table 54. ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 55. ICON (incl. PRA Health) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 56. ICON (incl. PRA Health) Recent Development
 Table 57. PPD(Pharmaceutical Product Development) Company Details
 Table 58. PPD(Pharmaceutical Product Development) Business Overview
 Table 59. PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 60. PPD(Pharmaceutical Product Development) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 61. PPD(Pharmaceutical Product Development) Recent Development
 Table 62. Laboratory Corporation Company Details
 Table 63. Laboratory Corporation Business Overview
 Table 64. Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 65. Laboratory Corporation Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 66. Laboratory Corporation Recent Development
 Table 67. Syneos Health Company Details
 Table 68. Syneos Health Business Overview
 Table 69. Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 70. Syneos Health Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 71. Syneos Health Recent Development
 Table 72. Parexel Company Details
 Table 73. Parexel Business Overview
 Table 74. Parexel Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 75. Parexel Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 76. Parexel Recent Development
 Table 77. Covance Company Details
 Table 78. Covance Business Overview
 Table 79. Covance Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 80. Covance Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 81. Covance Recent Development
 Table 82. Charles River Laboratories Company Details
 Table 83. Charles River Laboratories Business Overview
 Table 84. Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 85. Charles River Laboratories Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 86. Charles River Laboratories Recent Development
 Table 87. Wuxi AppTec Company Details
 Table 88. Wuxi AppTec Business Overview
 Table 89. Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 90. Wuxi AppTec Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 91. Wuxi AppTec Recent Development
 Table 92. Pharmaron Inc. Company Details
 Table 93. Pharmaron Inc. Business Overview
 Table 94. Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 95. Pharmaron Inc. Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 96. Pharmaron Inc. Recent Development
 Table 97. Hangzhou Tigermed Consulting Company Details
 Table 98. Hangzhou Tigermed Consulting Business Overview
 Table 99. Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 100. Hangzhou Tigermed Consulting Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 101. Hangzhou Tigermed Consulting Recent Development
 Table 102. IQVIA Company Details
 Table 103. IQVIA Business Overview
 Table 104. IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 105. IQVIA Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 106. IQVIA Recent Development
 Table 107. Joinn Laboratories (China) Company Details
 Table 108. Joinn Laboratories (China) Business Overview
 Table 109. Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Product
 Table 110. Joinn Laboratories (China) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
 Table 111. Joinn Laboratories (China) Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical R&D Outsourcing Services (CRO) Picture
 Figure 2. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Type: 2025 vs 2032
 Figure 4. Chemical Drug Research And Development Features
 Figure 5. Biological Drug Research And Development Features
 Figure 6. Traditional Chinese Medicine Research And Development Features
 Figure 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Application: 2025 vs 2032
 Figure 9. Drug Discovery And Early Research Case Studies
 Figure 10. Preclinical Research Case Studies
 Figure 11. Clinical Trials Case Studies
 Figure 12. Post-Marketing Follow-Up Case Studies
 Figure 13. Other Case Studies
 Figure 14. Pharmaceutical R&D Outsourcing Services (CRO) Report Years Considered
 Figure 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 16. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region: 2025 vs 2032
 Figure 18. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Players in 2025
 Figure 19. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Pharmaceutical R&D Outsourcing Services (CRO) Revenue in 2025
 Figure 21. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2021–2032)
 Figure 23. United States Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Canada Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2021–2032)
 Figure 27. Germany Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. France Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. U.K. Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Italy Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Russia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Ireland Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2021–2032)
 Figure 35. China Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Japan Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. South Korea Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Southeast Asia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. India Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Australia & New Zealand Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2021–2032)
 Figure 43. Mexico Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Brazil Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2021–2032)
 Figure 47. Israel Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. UAE Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. IQVIA HOLDINGS Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 51. ICON (incl. PRA Health) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 52. PPD(Pharmaceutical Product Development) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 53. Laboratory Corporation Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 54. Syneos Health Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 55. Parexel Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 56. Covance Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 57. Charles River Laboratories Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 58. Wuxi AppTec Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 59. Pharmaron Inc. Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 60. Hangzhou Tigermed Consulting Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 61. IQVIA Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 62. Joinn Laboratories (China) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS